Lexeo Therapeutics, Inc. Common Stock (LXEO)
Healthcare
Biotechnology
—
4.10 $
-5.1%
vs. previous close
Closing price · As of: 31. Jul 2026
Lexeo Therapeutics, Inc. Common Stock (LXEO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -21 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -13 | -14 | -14 | -15 | -20 | -18 | -28 | -22 | -27 | -30 | -20 | -21 | -98 | |
| 0.4 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.9 | 0.0 | 2.0 | |
| 1.0 | 0.9 | 0.8 | 2.3 | 2.8 | 3.8 | 3.5 | 3.7 | 3.1 | 2.7 | 2.7 | 2.8 | 11 | |
| -1.2 | 4.6 | -1.3 | 4.0 | -2.3 | 7.4 | -6.4 | 6.7 | -1.3 | -13 | -2.4 | -4.2 | -20 | |
| 0.0 | 0.1 | 0.1 | 0.2 | 0.2 | 0.1 | 0.0 | 0.0 | 0.1 | 0.3 | 0.0 | 0.0 | 0.4 | |
| 0.0 | -0.1 | -0.1 | -0.2 | -0.2 | -0.1 | -94 | 16 | -39 | 35 | -102 | 27 | -78 | |
| – | 0.0 | – | – | 0.0 | 0.0 | 0.0 | – | – | 80 | -80 | – | – | |
| – | – | – | – | – | -0.1 | -0.1 | -0.2 | -0.1 | -0.1 | -0.2 | -0.1 | -0.5 | |
| -0.1 | 3.9 | 100 | 89 | 0.3 | -0.1 | -0.1 | 0.0 | 73 | 0.1 | 144 | 2.5 | 219 | |
| -13 | -10 | 86 | 74 | -20 | -18 | -122 | -6.1 | 6.6 | 5.5 | 22 | 8.8 | 43 | |
| -13 | -14 | -14 | -15 | -20 | -18 | -28 | -22 | -27 | -30 | -20 | -21 | -98 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.